Abstract | OBJECTIVE: DATA SOURCES: A search of biomedical literature was completed through MEDLINE and EMBASE (1993-May 2002) to identify all clinical trials pertaining to the use of gabapentin for the treatment of tremor in humans. DATA SYNTHESIS: Outcome data from the few published studies have varied widely. Patient groups have been small, and conclusions have been based largely on subjective patient and investigator ratings. CONCLUSIONS: A trial of gabapentin is warranted in patients who fail therapy with traditional agents. Improvement should be measured by a patient's perceived functional ability.
|
Authors | Michele A Faulkner, John M Bertoni, Thomas L Lenz |
Journal | The Annals of pharmacotherapy
(Ann Pharmacother)
Vol. 37
Issue 2
Pg. 282-6
(Feb 2003)
ISSN: 1060-0280 [Print] United States |
PMID | 12549962
(Publication Type: Journal Article, Review)
|
Chemical References |
- Acetates
- Amines
- Cyclohexanecarboxylic Acids
- gamma-Aminobutyric Acid
- Gabapentin
|
Topics |
- Acetates
(therapeutic use)
- Adult
- Aged
- Amines
- Clinical Trials as Topic
- Cyclohexanecarboxylic Acids
- Gabapentin
- Humans
- Middle Aged
- Parkinson Disease
(drug therapy)
- Treatment Outcome
- Tremor
(classification, drug therapy, etiology)
- gamma-Aminobutyric Acid
|